Sign in

Carles Foguet

@cfoguet.bsky.social
66 followers 129 following 56 posts

Català vivint a UK. Researcher at the BHF Cardiovascular Epidemiology Unit at Cambridge University. cfoguet.github.io

PostsRepliesMedia
Reposted by Carles Foguet
Guillaume Méric @gmeric.bsky.social · 22/09/2026
We have a ✨PhD studentship✨ on olfactory genetics and the gut microbiota supervised by Dr Kaitlin Wade @bristoluni.bsky.social /Bristol Med School & me @uniofbath.bsky.social → Check it out! (incl GW4 selection process, eligibility & target candidate profiles) www.findaphd.com/phds/project...
findaphd.com
GW4 BioMed3 MRC DLP PhD project: Understanding the impact of olfactory genetics, diet and gut microbiota on cardiometabolic health at University of Bath on FindAPhD.com
PhD Project - GW4 BioMed3 MRC DLP PhD project: Understanding the impact of olfactory genetics, diet and gut microbiota on cardiometabolic health at University of Bath, listed on FindAPhD.com
025
Reposted by Carles Foguet
NEJM.org @nejm.org · 23/09/2026
David J. Hunter, MB, BS, FMedSci, and Michael Inouye, PhD, review the ways common genetic variants, polygenic risk scores, and pharmacogenomic genotyping may be useful in the prevention of common diseases and the treatment of common diseases after diagnosis. Full review: nej.md/4Amwv0F
An illustrated diagram from the Review Article "Clinical Uses of Common Genetic Variants Associated with Common Diseases" that shows the levels of human genome analysis and implications for analysis of disease risk and diagnosis.
0197
Reposted by Carles Foguet
BHF Cardiovascular Epidemiology Unit at Cambridge @cambridge-ceu.bsky.social · 15/09/2026
🧬 New research led by @cfoguet.bsky.social , @iamslambert.bsky.social and @mikeinouye.bsky.social , published in Nature Genetics! OmicsPred brings together genetic prediction models for genes, proteins and metabolites in a single platform. Read more here: tinyurl.com/23y7uym7
Headshots of Dr Carles Foguet, Dr Sam Lambert and Professor Mike Inouye
043
Reposted by Carles Foguet
Mike Inouye @mikeinouye.bsky.social · 15/09/2026
We are recruiting for a Postdoctoral Researcher in Biomedical AI to open up new frontiers at the interface of genetics, biochemistry and the use of population-scale data to guide development of therapeutics! www.cam.ac.uk/jobs/researc... Come do some blue sky research w/ me & @cfoguet.bsky.social 😁
01112
Reposted by Carles Foguet
Mike Inouye @mikeinouye.bsky.social · 08/09/2026
📣 New preprint out from the lab! “Enhanced power and transferability for genetics-driven metabolomic biomarker discovery in admixed American cohorts” tackles the important problem that many omics studies still have limited representation of admixed populations www.medrxiv.org/content/10.6...
1106
Reposted by Carles Foguet
Mike Inouye @mikeinouye.bsky.social · 01/09/2026
Chuffed to bits to see our OmicsPred resource paper just out @natgenet.nature.com! OmicsPred as a centralized resource for genetic prediction of multi-omic traits www.nature.com/articles/s41... Resource link: www.omicspred.org
1144
Reposted by Carles Foguet
Sam Lambert @iamslambert.bsky.social · 01/09/2026
Once again, OmicsPred is a team effort from UChicago (@hakyim.bsky.social), our Cambridge group (@mikeinouye.bsky.social @cfoguet.bsky.social @laurentgil33.bsky.social @yuxu.bsky.social) + many more! Stay tuned for a new tranche of scores out soon - submit yours at 🔗: www.omicspred.org/submit!
omicspred.org
042
Reposted by Carles Foguet
Sam Lambert @iamslambert.bsky.social · 01/09/2026
Now OmicsPred.org is released to the wild via @natgenet.nature.com, read the updated version (more metadata descriptions, cross-platform PheWAS comparison)! 🔗: rdcu.be/YRma6QaXW7ea
rdcu.be
184
Reposted by Carles Foguet
Mike Inouye @mikeinouye.bsky.social · 07/08/2026
Latest from our lab! A proteome-wide association study of cardiovascular diseases in 640,000 participants of multiple ancestries www.medrxiv.org/content/10.6... A truly global collaboration of computational and experimental researchers. h\t @yuxu.bsky.social, Doug Loesch, Henry Taylor among many!
0158
Reposted by Carles Foguet
The Polygenic Score Catalog @pgscatalog.bsky.social · 29/07/2026
A big day for ancestry-specific polygenic risk scores in the PGS Catalog, a phenome-wide atlas of scores for 241 traits (1501 PGS)! Check it out 🔗: www.pgscatalog.org/publication/...!
pgscatalog.org
PGS Catalog - Chen HH, Nature (2025) (Publication)
The Polygenic Score (PGS) Catalog is an open database of published PGS and the relevant metadata needed to apply and evaluate them correctly.
0105
Reposted by Carles Foguet
Mike Inouye @mikeinouye.bsky.social · 18/06/2026
Review from the lab just out in Cell Genomics: Translating genome-wide association studies at multiple scales: Drug target prioritization, cellular architectures, and organ imaging www.cell.com/cell-genomic... Co-led by fab PhD students Benedetta Felici and Siyuan Chen!
cell.com
Translating genome-wide association studies at multiple scales: Drug target prioritization, cellular architectures, and organ imaging
This review covers how the results of genome-wide association studies are now utilized at multiple scales, informing our etiological understanding at the levels of molecules, cells, and organs. It cov...
0125
Reposted by Carles Foguet
Mike Inouye @mikeinouye.bsky.social · 09/06/2026
Huge congrats to @xilinjiang.bsky.social (Wellcome fellow in the group) on his first senior author paper, in @natgenet.nature.com no less! 👏👏👏👏 Pleiotropic shared heritability quantifies the shared genetic variance of common diseases www.nature.com/articles/s41...
nature.com
Pleiotropic shared heritability quantifies the shared genetic variance of common diseases - Nature Genetics
Pleiotropic shared heritability with bias correction (PHBC) estimates the genetic variance of a target disease that is shared with a set of auxiliary diseases. Applying PHBC to diseases in the UK Biob...
084
Reposted by Carles Foguet
Mike Inouye @mikeinouye.bsky.social · 09/06/2026
Super chuffed to see our latest preprint is out: Polygenic risk of cardiovascular disease manifests in cardiac structure and function 👉 www.medrxiv.org/content/10.6... A collaborative study led by exceptional PhD student Benedetta Felici!
0174
Reposted by Carles Foguet
Kaur Alasoo @kauralasoo.bsky.social · 23/10/2024
Happy to share our most recent GWAS meta-analysis of 249 circulating metabolic biomarkers (Nightingale Health platform) in up to 619,372 individuals. www.medrxiv.org/content/10.1...
1147
Reposted by Carles Foguet
Sam Lambert @iamslambert.bsky.social · 20/05/2026
@omicspred.bsky.social centralises imputation models from multiple resources (PredictDB, Zenodo, INTERVAL/UKB-trained scores) and multiple omics layers (transcriptomics, metabolomics, proteomics) to make analyses easier and more comprehensive, e.x. this multi-ancestry multi-omics MVP PheWAS!
134
Reposted by Carles Foguet
Sam Lambert @iamslambert.bsky.social · 20/05/2026
Interested in applying multi-omics imputation or TWAS/PWAS approaches to your data? Frustrated by the models being spread across multiple resources? Enter OmicsPred: a centralised resource for genetic prediction of multi-omic traits! 🔗 : www.omicspred.org 📃 : www.medrxiv.org/content/10.6...
11910
Reposted by Carles Foguet
Mike Inouye @mikeinouye.bsky.social · 20/05/2026
OmicsPred (www.omicspred.org) has been almost completely overhauled with new front-end, back-end, features, pheWAS and multi-omic scores (>3 million and counting).
medrxiv.org
OmicsPred as a centralised resource for genetic prediction of multi-omic traits
Genetic prediction of multi-omic data has emerged as a cost-effective alternative to direct omics profiling, particularly useful for identifying molecular features associated with disease susceptibili...
163
Reposted by Carles Foguet
Mike Inouye @mikeinouye.bsky.social · 20/05/2026
Wonderful to see the new integrated OmicsPred resource now preprinted at medrxiv: "OmicsPred as a centralised resource for genetic prediction of multi-omic traits" www.medrxiv.org/content/10.6... OmicsPred: www.omicspred.org
1117
Reposted by Carles Foguet
Mike Inouye @mikeinouye.bsky.social · 13/03/2026
Important work for stratifying risk of heart failure in Europe. Prediction of incident heart failure in individuals without prior cardiovascular disease: the SCORE2-HF risk model academic.oup.com/eurheartj/ad...
472
Reposted by Carles Foguet
Department of Public Health and Primary Care @dphpc.bsky.social · 09/03/2026
BHF 4-Year Studentship - Closing Date 16 April 2026 www.cam.ac.uk/jobs/bhf-4-y...
cam.ac.uk
BHF 4-Year PhD Studentships in Cardiovascular Disease Prevention
University of Cambridge, University of Edinburgh, Imperial College London and University of Oxford Applications are invited for up to 10 funded 4-year PhD studentships starting in October 2026, as
033
Reposted by Carles Foguet
Patrick Gibbs @patrickgibbs.bsky.social · 28/02/2026
Happy to share new manuscript I completed with @ee-reh-neh.bsky.social & @davisjmcc.bsky.social back in Melbourne. The work originally conceived by @ijbeasley.bsky.social focuses on how we can reconcile and meta-analyse eQTL studies across studies cohorts and ancestries. doi.org/10.64898/202...
doi.org
Power is a major confounder in the analysis of cross-ancestry 'portability' in human eQTLs
The phenotypic effects of germline variants are often mediated through gene regulation. Expression quantitative trait loci (eQTLs) are genetic variants associated with changes in gene expression. Understanding how eQTLs vary across populations is essential for characterising the genetic and regulatory drivers of trait diversity. Meta-analysing eQTL studies from multiple populations enables more robust detection of eQTLs and can reveal regulatory mechanisms shaped by population-specific environmental or ancestry-related factors. However, across the multi-ancestry eQTL literature, a wide range of methods have been used to quantify eQTL portability across ancestry groups. Because different studies employ different portability metrics, it is challenging to form a coherent view of the regulatory landscape across populations. In this work, we analyse eQTL summary statistics from ten datasets matched on tissue type and sequencing technology. We compare portability metrics used previously and show that they can yield markedly different patterns of apparent regulatory conservation or divergence. We then examine the statistical determinants of portability across metrics and demonstrate that sample size, minor allele frequency, and linkage disequilibrium are major drivers of the observed differences in eQTL portability across studies. These findings highlight that differences in statistical power stemming from factors such as population size and allele frequency must be accounted for when evaluating eQTL portability. To address this issue, we introduce a new approach designed to correct for these factors when calling eQTL portability. Finally, we show that empirical Bayes multivariate adaptive shrinkage provides a powerful framework for meta-analysing multiple eQTL studies, with the ability to pool signals across populations to produce more robust effect-size estimates within each population. ### Competing Interest Statement The authors have declared no competing interest. National Health and Medical Research Council, https://ror.org/011kf5r70, Ideas Grant 2020501, Investigator Grant 1195595
01912
Reposted by Carles Foguet
Brian Cutts @briancutts.bsky.social · 23/02/2026
Mother Language Day, yet they focus on the 24 "official" ones instead of the 200+ "minority" mother languages making up the true cultural diversity of Europe 🤦
12720
Reposted by Carles Foguet
UK Biobank @ukbiobank.ac.uk · 11/02/2026
Yesterday the UK Government published a data provision notice paving the way for coded GP data in England to be shared with consented cohorts like UK Biobank. Hear from Val, a UK Biobank participant on her hopes for the future.
263
Reposted by Carles Foguet
Mike Inouye @mikeinouye.bsky.social · 30/01/2026
Very much enjoyed the Festival of Genomics and BioData yesterday in London eventhough I could only be there a few hours! Highlight has to be meeting Prof Marta Cascante, a pioneer of metabolomics and using metabolic flux analysis to identify new metabolic drug targets! web.ub.edu/en/web/actua...
web.ub.edu
Professor Marta Cascante, honorary fellow of the Metabolomics Society
162
Reposted by Carles Foguet
Mike Inouye @mikeinouye.bsky.social · 26/01/2026
The STRIDES Trial: Largest ever trial (N~1,300,000) of interventions for blood donor vasovagal reactions (feeling faint and fainting) shows no benefit from four additional interventions www.thelancet.com/journals/lan... Simplifies the service, saves £££ and focuses time/effort elsewhere 👏👏👏
thelancet.com
Preventive interventions for vasovagal reactions in whole blood donors: a cluster-randomised, stepped-wedge, crossover trial of 73 sites involving 1·4 million donors in England
Four interventions used to prevent donation-related vasovagal reactions showed no clear benefits compared with standard practices in England, suggesting potential policy implications for blood service...
052
Reposted by Carles Foguet
Bellingcat @bellingcat.com · 24/01/2026
Federal law enforcement agents shot and killed a man in Minneapolis on Jan. 24 according to local police officials. DHS told Fox News that the man was “armed with a gun”. A video of the shooting appears to show that a gun was taken from the man before the first shot was fired. x.com/BillMelugin_...
22353092693
Reposted by Carles Foguet
The Polygenic Score Catalog @pgscatalog.bsky.social · 15/12/2025
Wish it was easier to calculate PGS in trusted research environments (TRE) like DNAnexus or the All of Us workbench? Us to! We've been hard at work on a new version of pgsc_calc to make it more scalable in those TREs! Introducing pgsc_calc v3.0.0-alpha.1: pgsc-calc.readthedocs.io/en/v3-alpha.1/
buff.ly
pgsc_calc: a reproducible workflow to calculate polygenic scores | PGS Catalog Calculator documentation.
The `pgsc_calc` workflow makes it easy to calculate a polygenic score
197
Reposted by Carles Foguet
BHF Cardiovascular Epidemiology Unit at Cambridge @cambridge-ceu.bsky.social · 15/12/2025
New paper alert! @sritchie73.bsky.social @mikeinouye.bsky.social & team found integrating genetic & metabolic blood tests with existing clinical data could enhance how doctors identify people at high risk of heart disease, leading to earlier prevention strategies Read more tinyurl.com/bp5tjck2
tinyurl.com
Combined clinical, metabolomic, and polygenic scores for cardiovascular risk prediction
AbstractBackground and Aims. Clinical biomarkers, nuclear magnetic resonance (NMR) metabolomics biomarker scores, and polygenic risk scores (PRS) have show
043
Reposted by Carles Foguet
Guillaume Méric @gmeric.bsky.social · 12/11/2025
New PhD position in my lab at @uniofbath.bsky.social (with both @tweethinking.bsky.social & Dr Bethan Littleford-Colquhoun)! We're looking for someone keen on bioinformatics and microbiome evolution. Important info below on eligibility & URSA competition funding👇 www.findaphd.com/phds/project...
findaphd.com
The overlapping microbiome: ecology, function and resilience beyond species boundaries at University of Bath on FindAPhD.com
PhD Project - The overlapping microbiome: ecology, function and resilience beyond species boundaries at University of Bath, listed on FindAPhD.com
11925
Reposted by Carles Foguet
Max Berger @maxberger.bsky.social · 23/11/2025
If I’m understanding this correctly, X is owned by a white nationalist who pays poor people of color in developing countries to pretend to be working class white Americans to scare other white Americans into being afraid poor people of color from developing countries are going to ruin America?
9693989011615
Reposted by Carles Foguet
Mike Inouye @mikeinouye.bsky.social · 22/11/2025
📣📣📣 Excited for our lab's latest preprint, led by Chief Ben-Eghan! www.medrxiv.org/content/10.1... tl;dr We identify protein vQTLs in multiple ancestries then use MVMR to show independent effects of mean & variance on disease, suggesting targeting protein variance could have therapeutic potential.
1289
Reposted by Carles Foguet
Randall Munroe @xkcd.com · 22/10/2025
Emperor Palpatine xkcd.com/3157/
Comic. Scatter chart with Emperor Palpatine character age on Y axis and Ian McDiarmid age during filming on X axis. Plot with descending arrow beginning from Return of the Jedi (emperor age 90, McDiarmid age 40) → Revenge of the Sith, Attack of the Clones, and The Phantom Menace (emperor age 50-70, McDiarmid age 50-60) → The Rise of Skywalker (cloned body, undefined age) with a gradient vertical line (McDiarmid age over 70) → Now (emperor age under 10, McDiarmid age over 80). [caption] To continue the trend, they should make a Star Wars movie where 81-year-old Ian McDiarmid plays the emperor as a toddler.
322504327
Reposted by Carles Foguet
Sam Lambert @iamslambert.bsky.social · 19/09/2025
Algorithmic fairness metrics have made big inroads in the AI/ML fields to investigate model bias. A clever PhD student (@clairecoffey.bsky.social) thought, why don't you see these methods applied to CVD risk prediction or polygenic risk scores? Enter our new preprint: www.medrxiv.org/content/10.1...
medrxiv.org
Current polygenic risk scores are unlikely to exacerbate unfairness in cardiovascular disease risk prediction
Background: Current cardiovascular disease (CVD) risk prediction models place many individuals in an intermediate risk category where clinical decision-making remains uncertain, highlighting a…
1176
Reposted by Carles Foguet
Loïc Lannelongue @loiclnlg.bsky.social · 15/09/2025
⏰ Last couple of days to apply to join my group @Cambridge as a postdoc and work on the environmental (un)sustainability of AI! ⏳ Closing September 16th. ✏️ Apply here: tinyurl.com/2ukkp8yx Or learn more about what we do at www.lannelongue-group.org Initial examples of research projects below 👇
cam.ac.uk
Research Associate*/Research Assistant in Sustainability of AI (Fixed Term)
An exciting opportunity has arisen for a talented researcher to join our team as part of the Green Algorithms Initiative, one of the leading academic teams in the field of sustainable computing. The
1109
Reposted by Carles Foguet
jen sometimes aph 🌻 @bunnibytz.bsky.social · 02/09/2025
KASIE HUNT: Over the summer you said, “There’s no vaccine that’s safe and effective”. Do you still believe that? RFK JR: “I never said that.” KASIE HUNT: “Play the clip.” RFK JR (clip): “There’s no vaccine that is safe and effective.” (March 2024) ht: @cwebbonline.com
1044154904407
Reposted by Carles Foguet
Jeremy Berg @jeremymberg.bsky.social · 01/09/2025
Yes, it was carefully hidden in the New England Journal of Medicine. Pfizer/BioNTech vaccine (www.nejm.org/doi/pdf/10.1... ) 1/2
A graph comparing COVID incidence after the Pfizer vaccine compared to placebo
762825826
Reposted by Carles Foguet
Daniel Lakens @lakens.bsky.social · 15/08/2025
An abbreviation (ABB) in a journal article (JA) or Grant Application (GA) is rarely worth the words it saves. Every ABB requires cognitive resources (CR) and at my age by the time I'm halfway through a JA or GA I no longer have the CR to remember what your ABB stood for.
12447132
Reposted by Carles Foguet
European Commission @ec.europa.eu · 05/08/2025
Double the discovery, double the momentum 🚀 Europe doubles down on research competitiveness with a major boost to #HorizonEurope: €95.5 billion foreseen for 2021-2027 💰💰💰💰💰💰💰💰💰 €175 billion proposed for 2028-2034 💰💰💰💰💰💰💰💰💰💰💰💰💰💰💰💰💰💰
420557
Reposted by Carles Foguet
Jakub Janovsky @rebel44cz.bsky.social · 10/07/2025
The Guardian's take on the new interim NASA administrator: "Duffy has no scientific background, but does have experience with transportation, as a former contestant on the MTV reality TV game show Road Rules, a Winnnebago driving contest." the USA is soooooo fucked...
1434661
Reposted by Carles Foguet
OmicsPred @omicspred.bsky.social · 16/06/2025
We're working closely with our PredictDB colleagues to bring you an integrated resource for multi-omic predictors We're happy to announce that PrediXcan GTExV8 expression predictors are now annotated and openly available via OmicsPred! www.omicspred.org More info www.omicspred.org/publication/...
omicspred.org
OmicsPred is an atlas of genetic scores for prediction of multi-omics data.
0136
Reposted by Carles Foguet
Mike Inouye @mikeinouye.bsky.social · 16/06/2025
Super excited to see beginning integration of PredictDB into OmicsPred! We've annotated/deposited the GTExV8 gene expression predictors so they are now available alongside all the other multi-omic predictors at www.omicspred.org More on its way... a wonderful collab with @hakyim.bsky.social & co!
0188
Reposted by Carles Foguet
Mike Inouye @mikeinouye.bsky.social · 05/06/2025
📣 Latest from the lab: Performance of deep-learning-based approaches to improve polygenic scores www.nature.com/articles/s41... Its thought deep learning will substantially improve PGS but the reality is MANY have tried but no/little gain has been seen so far. Here we report our negative results.
419782
Reposted by Carles Foguet
Sam Lambert @iamslambert.bsky.social · 24/05/2025
@hasanga.bsky.social from @mikeinouye.bsky.social / @cambridgebaker.bsky.social @cambridge-ceu.bsky.social sharing new results for local-ancestry effects on CAD risk loci. #ESHG2025
Hasanga presenting at ESHG 2025
0189
Reposted by Carles Foguet
Mike Inouye @mikeinouye.bsky.social · 20/05/2025
ICYMI: Identification of plasma proteomic markers underlying polygenic risk of type 2 diabetes and related comorbidities www.nature.com/articles/s41... Collaboration with @astra-zeneca.bsky.social throwing up very interesting targets including FAM3D (T2D), ITIH4 & EFEMP1 (CVD in those with T2D)
nature.com
Identification of plasma proteomic markers underlying polygenic risk of type 2 diabetes and related comorbidities - Nature Communications
Here, the authors leveraged genetic and proteomic information from the UK Biobank and two randomized controlled trials to characterize how polygenic disease risk for T2D and related comorbidities pert...
082
Reposted by Carles Foguet
BHF Cardiovascular Epidemiology Unit at Cambridge @cambridge-ceu.bsky.social · 19/05/2025
We are now on Bluesky! Follow us to keep up to date with our research and find out what goes on at the Cardiovascular Epidemiology Unit in the @dphpc.bsky.social #cardiovasculardisease #prevention #healthcare #bigdata #globalhealth #publichealth #riskfactors
0108
Reposted by Carles Foguet
Sam Lambert @iamslambert.bsky.social · 14/05/2025
Are you a new PhD interested in cardiovascular disease, big data, cohorts, or multi-omics? Join our Cardiovascular Epidemiology Unit at the University of Cambridge for a British Heart Foundation-funded postdoctoral position. Open to those not currently in the CVD field. 🔗: buff.ly/R7YJvfl
buff.ly
Research Assistant/Research Associate* in Cardiovascular Epidemiology (BHF Scholarship) (Fixed Term) - Job Opportunities - University of Cambridge
Research Assistant/Research Associate* in Cardiovascular Epidemiology (BHF Scholarship) (Fixed Term) in the Department of Public Health and Primary Care, Cardiovascular Epidemiology Unit at the…
177
Reposted by Carles Foguet
Rafeeque Mavoor @rafeequemavoor.bsky.social · 13/05/2025
🧵5 Top Free Alternatives to BioRender for Scientific Illustrations! These five websites offer free scientific illustrations for biologists. Great for presentations, research papers and other research communication needs. Save and share the post!
32679350
Reposted by Carles Foguet
Mike Inouye @mikeinouye.bsky.social · 12/05/2025
📣 Psychological & behavioural considerations for integrating polygenic risk scores for disease into clinical practice www.nature.com/articles/s41... Saskia Sanderson & I wrote a piece assessing the common concern that PRS may have psych/behavioural harms tl;dr 👉 There's little/no evidence for this
02313
Reposted by Carles Foguet
Loïc Lannelongue @loiclnlg.bsky.social · 09/05/2025
📣 Interested in the environmental (un)sustainability of AI (and how to support positive change)? Or know someone who is? I have an open position for a postdoctoral researcher to join my group in Cambridge, UK 🌱 🚨Closing June 5th www.jobs.cam.ac.uk/job/51255/ Topics below 👇 #AcademicSky #GreenSky
Photo of Cambridge River and view over King's College with a group of people punting.Photo of the Heart and Lungs Research Institute on Cambridge Biomedical Campus. The building is bronze-colour and in front of a pond.
12016